Author

Mária Matuz 1

1 University of Szeged,Szeged,Hungary

BODY-MASS INDEX CORRELATES WITH SEVERITY AND MORTALITY IN ACUTE PANCREATITIS - A META-ANALYSIS

Dalma Dobszai, Péter Mátrai, Zoltán Gyöngyi, Mária Matuz, Dezső Csupor, Judit Bajor, Balint Eross, Lajos Szakó, Ágnes Meczker, Roland Hágendorn, Katalin Márta, Andrea Szentesi, Peter Hegyi

CLINICAL ROLE, OPTIMAL TIMING AND FREQUENCY OF MEASUREMENT OF SERUM INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODY TITERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Renáta Bor, Klaudia Farkas, Anita Balint, Ágnes Milassin, Mariann Rutka, Mária Matuz, Ferenc Nagy, Anna Fabian, Zoltan Gabor Szepes, Tamás Molnár

LONG-TERM EFFICACY OF VEDOLIZUMAB THERAPY ON CLINICAL AND ENDOSCOPIC ACTIVITY IN PATIENTS WITH ANTI-TUMOR NECROSIS FACTOR ALPHA RESISTANT INFLAMMATORY BOWEL DISEASE

Renáta Bor, Zoltan Gabor Szepes, Mária Matuz, Klaudia Farkas, Anna Fabian, Pal Miheller, Karoly Palatka, Tamás Szamosi, Aron Vincze, Lilla Laura Lakner, Katalin Müllner, Mária Papp, Ágnes Szabone Dr Salamon, Eszter Schäfer, Krisztina Fülöpné Sarang, Ferenc Nagy, Ferenc Zsigmond, János Banai, Kata Szántó, Anita Balint, M

MEASUREMENT OF FAECAL INFLIXIMAB IN ULCERATIVE COLITIS POTENTIALLY INCREASES THE ACCURACY OF DISEASE MONITORING AND EVALUATION OF THERAPEUTIC RESPONSE

Klaudia Farkas, Kata Szántó, Diána Kata, Imre Földesi, Mária Matuz, Mariann Rutka, Renáta Bor, Anna Fabian, Tamás Resál, Ferenc Nagy, Zoltan Gabor Szepes, Tamás Molnár

PROACTIVE MEASUREMENT OF FAECAL INFLIXIMAB IN ULCERATIVE COLITIS POTENTIALLY INCREASES THE ACCURACY OF DISEASE MONITORING AND HELPS TO ACHIEVE THERAPEUTIC TARGET

Kata Judit Szántó, Diána Kata, Imre Földesi, Mária Matuz, Mariann Rutka, Renáta Bor, Anna Fabian, Tamás Resál, Péter Bacsur, Boldizsár Jójárt, József Maléth, Anita Balint, Ágnes Milassin, Ferenc Nagy, Zoltán Szepes, Tamás Molnár, Klaudia Farkas

Short- and long-term efficacy of vedolizumab therapy on clinical and endoscopic activity in patients with anti-tumor necrosis factor alpha resistant inflammatory bowel disease

Renáta Bor, Klaudia Farkas, Pal Miheller, Karoly Palatka, Tamás Szamosi, Aron Vincze, Mária Matuz, Mariann Rutka, Kata Szántó, Tibor Tóth, Anita Balint, Szepes Zoltán, Ferenc Nagy, Ágnes Milassin, Anna Fabian, Ferenc Zsigmond, Judit Bajor, Lilla Laura Lakner, Müllner Katalin, Katalin Müllner, Mária Papp, Ágnes Szabone

USTEKINUMAB IS ASSOCIATED WITH SUPERIOR TREATMENT PERSISTENCE BUT NOT WITH HIGHER REMISSION RATES COMPARED TO VEDOLIZUMAB IN REFRACTORY CROHN’S DISEASE PATIENTS: RESULTS FROM A MULTICENTRE COHORT STUDY

Péter Bacsur, Mária Matuz, Tamás Resál, Pal Miheller, Tamás Szamosi, Eszter Schäfer, Patrícia Sarlós, Ákos Iliás, Kata Judit Szántó, Mariann Rutka, Anita Balint, Ágnes Milassin, Anna Fabian, Renáta Bor, Szepes Zoltán, Tamás Molnár, Klaudia Farkas

Item 1 - 7 / 7
1